Wissenschaftliche Arbeiten

Prof. Dr. Evren Özdemir

153 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. Ok E, Özdemir E, Tokat Y, Hoşcoşkun C, Töbü M, Karaca E, Akçiçek F, Başçı A. Renal Transplant alıcılarında hepatik göstergeler; etiolojik göstergeleri aydınlatmaya yönelik retrospektif çalışma. X. Ulusal Nefroloji Kongresi, Bursa, Abstrakt Kitabı, sf. 38, 19-22 Ekim 1993.

    Quelle: Profilseite auf medicana.com.tr

  2. Özdemir E, Ok E, Kürşat S, Cirit M, Başak K, Töz H, Akalın E, Atabay G. Kronik erişkin hemodiyaliz hastalarında hepatik göstergeler; etiolojik ilişkileri inceleyen retrospektif çalışma. X. Ulusal Nefroloji Kongresi, Bursa, Abstrakt Kitabı, sf. 177, 19-22 Ekim 1993.

    Quelle: Profilseite auf medicana.com.tr

  3. Aslan A, Turker A, Kars A, Barista I, Özdemir E. Rituximab in Combination with Cyclophosphamide, Mitoxantrone, Vincristine and Prednisone (R-CNOP) As First Line Regimen in Elderly Patients with Diffuse Large B-Cell Lymphoma Blood 128:5390, 2016.

    Quelle: Profilseite auf medicana.com.tr

  4. Aslan T, Özdemir E, Uner A, Gungor E, Aslan NA, Yildizhan E, Agit A, Korkmaz S, Cagliyan GA, Barista I, Ozhamam E, Pamuk GE, Turgut M, Eser B, Ozet G, Yıldırım R, Buyukasik Y. Splenic Marginal Zone Lymphoma in an East Mediterranean/Middle Eastern Population Cohort: Possible Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Prognostic Factor (ThREG-NHL01 Study). Blood 128:5332, 2016.

    Quelle: Profilseite auf medicana.com.tr

  5. Bahcecioglu AB, Etgul S, Aslan T, Aydın MS, Malkan UY, Okay M, Özdemir E, Ciftciler R, Goker H, Buyukasik Y. Experience with Pegylated Interferon α-2a in 30 Patients Diagnosed with Hematologic Neoplasms. Blood 128:5483, 2016.

    Quelle: Profilseite auf medicana.com.tr

  6. Özdemir E, Aslan A, Turker A, Barısta I, Kars A. Gemcitabine in combination with oxaliplatin (GemOx) as a salvage regimen in patients with relapsed/refractory Hodgkin’s lymphoma. Poster Presentation 57th ASH Annual Meeting, December 5-7, 2015. Blood 126 (23):1517, 2015.

    Quelle: Profilseite auf medicana.com.tr

  7. Özdemir E, Aslan A, Turker A, Barısta I, Kars A. Single agent gemcitabine as a salvage regimen in patients with relapsed/refractory Hodgkin’s lymphoma after autologous stem cell transplantation. Blood 126 (23):5090, 2015.

    Quelle: Profilseite auf medicana.com.tr

  8. Özdemir E, Akın S. Atypical recurrence of mantle cell lymphoma three years after autologous stem cell transplantation mimicking soft tissue sarcoma. Poster Presentation, Poster No:18, Lymphoma and Myeloma 2015: An International Congress on Hematologic Malignancies, New York, NY, 22-24 October 2015.

    Quelle: Profilseite auf medicana.com.tr

  9. Tuglular ATF, Pehlivan M, Sari HI, Ayyildiz MO, Saydam G, Sonmez M, Besisik SK, Ozgur G, Gurkan E, Kaynar L, Ali R, Ozet G, Demirkan F, Ongoren S, Ozdogu H, Gunduz E, Tiftik EN, Salim O, Turgut M, Hacihanefioglu A, Ure UB, Özdemir E, Altuntas F, Simsek D, Ulu N, Beksac M. Post-authorization safety of lenelidomide + dexamethasone in patients with relapsed/refractory multiple myeloma: early safety report of Turkish PASS Study. Haematologica 100 (s1): 734, 2015 (Abstract Book 20th Congress of the European Hematology Association, Vienna, June 2015)

    Quelle: Profilseite auf medicana.com.tr

  10. Sunar V, Yasar A, Sarici F, Esin E, Diker O, Lacin S, Turker A, Özdemir E, Barısta I, Kars A. A retrospective analysis of central nervous system lymphomas: single center experience. J Clin Oncol 33, 2015 (suppl; abstr e13053)

    Quelle: Profilseite auf medicana.com.tr

  11. Tekgunduz, A. I. E., Kaya, A. H., Goker, H., Özdemir, E., Iskender, D., Kocubaba, S., Koyikci, O., Altuntas, F. Biosimilar filgrastim (Leucostim (R)) seems to have similar efficacy in hematopoietic progenitor cell mobilization compared to original filgrastim (Neupogen (R)) and lenograstim (Granocyte (R)): a retrospective, multicenter analysis. Bone Marrow Transplantation Volume: 50, Pages: S338-S338, Supplement: 1, Meeting Abstract: P429, MAR 2015

    Quelle: Profilseite auf medicana.com.tr

  12. Goker H, Eliacik E, Altuntas F, Tekgunduz E, Özdemir E, Isik A, Kayikci O, Kaya AH, Aksu S, Haznedaroglu IC, Sayinalp N, Demiroglu H, Ozcebe OI, Buyukasik Y. Lower doses of Plerixafor use is sufficient to effectively mobilize PBSC (peripheral blood hematopoietic stem cells) when compared to standart administration. Blood, 124(21), 5830, Dec 6, 2014.

    Quelle: Profilseite auf medicana.com.tr

  13. Özdemir, E. Hodgkin’s Lymphoma: Diagnosis and Staging. Leukemia Research Volume: 38, Pages: S4-S4, Supplement: 1, Meeting Abstract: SP-010, OCT 2014

    Quelle: Profilseite auf medicana.com.tr

  14. Özdemir E. Nasal type natural killer/T cell lymphoma during the course of Behçet's Disease: A case report. Poster Presentation, Poster No:30, Lymphoma and Myeloma 2014: An International Congress on Hematologic Malignancies, New York, NY, 23-25 October 2014.

    Quelle: Profilseite auf medicana.com.tr

  15. Ferhanoglu B, Salihoglu A, Elverdi T, Karadogan I, Özdemir E, Erdem G, Karadurmus N, Akyol G, Kaynar L, Yegin A, Sucak G, Ozkocaman V, Topcuoglu P, Ozcan M, Birtas E, Goker H, Baslar Z, Paydas S. Brentuximab Vedotin for relapsed or refractory Hodgkin’s Lymphoma: Experience in Turkey. Haematologica 99 (s1): 675-676, 2014 (Abstract Book 19th Congress of the European Hematology Association, Milan, June 2014)

    Quelle: Profilseite auf medicana.com.tr

  16. Özdemir E, Doğan E, Gököz Ö. Thalidomide related leukocytoclastic vasculitis in two patients with multiple myeloma. Poster Presentation, Poster No:8, Lymphoma and Myeloma 2013: An International Congress on Hematologic Malignancies, New York, NY, 24-26 October 2013.

    Quelle: Profilseite auf medicana.com.tr

  17. Ozturk M, Arpaci F, Ozaydın S, Karadurmus N, Özdemir E, Ataergin S, Erdem G, karaca H, Cakar M, Turker T, Ozet A, Kuzhan O, Kilic S, Komurcu S, Ozet G, Dagdas S, Ozturk B, Sivgin S. High-dose chemotherapy and autologous stem cell transplantation in refractory/metastatic nonseminomatous germ cell-tumors: A retrospective study of the Turkish Oncology Association. J Clin Oncol 31, 2013 (suppl; abstr e 15623)

    Quelle: Profilseite auf medicana.com.tr

  18. Goker H, Özdemir E, Uz B, Buyukasik Y, Turgut M, Serefhanoglu S, Aksu S, Sayinalp N, Haznedaroglu IC, Tekin F, Unal S, Bektas O, Eliacik E, Isik A, Ozcebe OI. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for acute leukemia patients: a single center experience. Bone Marrow Transplantation 48: Issue S2:S537, April 2013.

    Quelle: Profilseite auf medicana.com.tr

  19. Özdemir E, Atasever T. Detection of multiple extramedullary plasmacytomas of upper airways by F-18 FDG PET/CT imaging. Poster Presentation, 14th International Myeloma Workshop, Kyoto, Japan, April 3-7, 2013. Clinical Lymphoma, Myeloma and Leukemia Vol 13, Suppl 1 pp. A1-A10, S132, April 2013 (Abstract Book 14th International Myeloma Workshop)

    Quelle: Profilseite auf medicana.com.tr

  20. Arslan C, Özdemir E, Barısta I, Turker A, Kars A, Ozısık Y, Kansu E. Efficacy and toxicity fof ICE (ifosphamide, carboplatin, and etoposide) IIVP (ifosphamide, idarubicin, and etoposide) salvage chemotherapy regimens in relapse/refractory Hodgkin lenfoma patients. J Clin Oncol 29, 2011 (suppl; abstr e 18563)

    Quelle: Profilseite auf medicana.com.tr

  21. Arslan C, Özdemir E, Dogan E, Ozisik Y, Altundag K. Secondary hematological malignancies after treatment of non-metastatic breast cancer. Haematologica 96 (s2):259, 2011 (Abstract Book 16th Congress of the European Hematology Association, London, June 2011)

    Quelle: Profilseite auf medicana.com.tr

  22. Arpaci F, Ozturk M, Özdemir E, Ozet A, Ataergin S, Dagdas S, Kuzhan O, Kilic S, Ozturk B, Komurcu S, Ozet G. Salvage high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with relapsed or refractory germ cell tumors: a Turkish Oncology Group Study. Poster Presentation, 35th Annual Meeting of the EBMT, Goteburg, Sweden, March 29-April 1, 2009. Bone Marrow Transplantation 43 (suppl 1), p:155-156, March 2009.

    Quelle: Profilseite auf medicana.com.tr

  23. Aksoy S, Kocal N, Akdogan S, Özdemir E. The prevalence and determinants of the use of complementary and alternative medicine in hematopoietic stem cell transplantation patients. Poster Presentation, BMT Tandem Meetings CIBMTR/ASBMT, San Diego, CA, February 13-18, 2008. Biology of Blood and Marrow Transplantation 14 (2) Suppl 2, Abstract No: 261, p:96-97, February 2008.

    Quelle: Profilseite auf medicana.com.tr

  24. Akgedik A, Akdogan S, Aksoy S, Özdemir E. The popsickle with strawberry aroma reduces infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells. Poster Presentation, BMT Tandem Meetings CIBMTR/ASBMT, San Diego, CA, February 13-18, 2008. Biology of Blood and Marrow Transplantation 14 (2) Suppl 2, Abstract No: 264, p:97-98, February 2008.

    Quelle: Profilseite auf medicana.com.tr

  25. Özdemir E, Koç Y, Kars A, Türker A, Tekuzman G, Kansu E. Bortezomib, dexamethasone and concomitant or sequential thalidomide (VTD): An effective combination for relapsed/refractory multiple myeloma failing thalidomide and dexamethasone. Blood 110(11):276B 4810 Part 2 Nov 16, 2007.

    Quelle: Profilseite auf medicana.com.tr

  26. Kıratlı P, Erbaş B, Özdemir E, Koç Y. Is there a predictive role for GA-67 scintigraphy in patients with lymphoma undergoing autologous stem cell transplantation? Haematologica-The Hematology Journal, 92:480-480 1332 Suppl. 1 Jun 2007. Komanduri KV, John LSS, Shpall EJ, Champlin RE, Molldrem JJ, Özdemir E. CMV reactivation after allogeneic stem cell transplantation is associated with a preponderance of circulating late-stage CMV-specific CD8+ T cells. Poster Presentation, 47th Annual Meeting of American Society of Hematology, Atlanta, GA. Blood, 106, 3250, Part 1, Nov 16 2005.

    Quelle: Profilseite auf medicana.com.tr

  27. Kiratli PO, Koc Y, Erbas B, Özdemir E. Predictive value of Ga-67 scintigraphy in patients with lymphoma undergoing autologous stem cell transplantation. European Journal of Nuclear Medicine and Molecular Imaging, 32, 26, September 2005. Oyan B, Koc Y, Özdemir E, Kansu E. High-dose sequential chemotherapy coupled with autologous PBSCT and in vivo purging with rituximab in patients with relapsed/refractory or high-risk B-cell NHL. Bone Marrow Transplantation, 35, 385, March 2005.

    Quelle: Profilseite auf medicana.com.tr

  28. Koc Y, Özdemir E, Oyan B, Kansu E. Nonmyeloablative Allogeneic Stem Cell Transplantation: Hacettepe University Institute of Oncology Experience. Blood, 104, 5155, Part 2, Nov 16 2004. Oyan B, Koc Y, Özdemir E, Kansu E. High-dose sequential chemotherapy (HDSC) in support of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory Hodgkin’s lymphoma (HL) and Non-Hodgkin’s lymphoma (NHL). Blood, 104, 5231, Part 2, Nov 16 2004.

    Quelle: Profilseite auf medicana.com.tr

  29. Özdemir E, Saliba R, Champlin RE, Komanduri KV. A model to predict risk for late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematologic malignancies. Poster Presentation, 46th Annual Meeting of American Society of Hematology, San Diego, CA. Blood, 104, 2241, Part 1, Nov 16 2004.

    Quelle: Profilseite auf medicana.com.tr

  30. Komanduri KV, Özdemir E, Gillespie G, St.John LS, Rowland-Jones S, Champlin RE, Molldrem JJ. Definitive evidence for an immunodominance hierarchy in the human CD8+ T cell response to Cytomegalovirus. Blood, 100, 5209, Part 2, Nov 16 2002.

    Quelle: Profilseite auf medicana.com.tr

  31. Özdemir E, St.John LS, Champlin RE, Molldrem JJ, Komanduri KV. Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with impaired cytomegalovirus-specific CD8+ T cell function. Poster Presentation. Trainee Recognition Day, MD Anderson Cancer Center, Houston, TX, May 8-10 2002.

    Quelle: Profilseite auf medicana.com.tr

  32. Özdemir E, St.John LS, Champlin RE, Molldrem JJ, Komanduri KV. Characterization of Immunodominance Hierarchies in the CD8+ T cell response to the Cytomegalovirus pp65 matrix protein. Poster Presentation. Trainee Recognition Day, MD Anderson Cancer Center, Houston, TX, May 8-10 2002

    Quelle: Profilseite auf medicana.com.tr

  33. Özdemir E, St.John LS, Gillespie G, Rowland-Jones S, Champlin RE, Molldrem JJ, Komanduri KV. Cytomegalovirus-specific CD8+ T cell recovery, as measured by HLA-peptide tetramer staining, is insufficient to control viremia following allogeneic stem cell transplantation. Poster Presentation, 43rd Annual Meeting of American Society of Hematology, Orlando, FL. Blood, 98, 1638, Part 1, Nov 16 2001.

    Quelle: Profilseite auf medicana.com.tr

  34. Özdemir E, Basu S, Winkelmann JC. HAR, a CD44 homolog, binds hyaluronic acid and has a highly conserved murine counterpart, mHAR. Blood, 94, 3921, Part 2, Suppl. 1, Nov 15 1999.

    Quelle: Profilseite auf medicana.com.tr

  35. Cirit M, Soydaş C, Özdemir E, Ok E, Kürşat S, Ünsal A, Mees EJ Dorhout. Functional valvular regurgitation in hemodialysis (HD) patients. XXXIIIrd Congress of the European Renal Association European Dialysis and Transplant Association, Amsterdam, The Netherlands, Abstract Book, page 87, June 18-21 1996.

    Quelle: Profilseite auf medicana.com.tr

  36. Özdemir E, Ok E, Kürşat S, Cirit C, Başak K, Töz H, Akalın E, Atabay G. Hepatic markers of chronic adult hemodialysis patients-a retrospective study investigating etiologic correlation. Kidney International, 48, 1680-1681, 1995.

    Quelle: Profilseite auf medicana.com.tr

  37. Dönmez A, Çal C, Özdemir E, Özyurt C, Hekimgil M, Çağırgan S, Çıkılı N, Büyükkeçeci F, Soydan S. Prostatic Involvement of Non-Hodgkin’s Lymphoma. XIIIth Meeting of the International Society of Hematology, İstanbul, Turkey, Abstract Book, Abst. 886, September 3-8, 1995.

    Quelle: Profilseite auf medicana.com.tr

  38. Şencan M, Çağırgan S, Tombuloğlu M, Dönmez A, Özdemir E, Büyükkeçeci F. Interferon alpha induced rheumatoid arthritis in a patient with hairy cell leukemia. XIIIth Meeting of the International Society of Hematology, İstanbul, Turkey, Abstract Book, Abst. 822, September 3-8, 1995.

    Quelle: Profilseite auf medicana.com.tr

  39. Töbü M, Tombuloğlu M, Çağırgan S, Özdemir E, Atamer M, Büyükkeçeci F. Diabetes insipitus in a case with acute myelogenous leukemia. XIIIth Meeting of the International Society of Hematology, İstanbul, Turkey, Abstract Book, Abst. 835, September 3-8, 1995.

    Quelle: Profilseite auf medicana.com.tr

  40. Çağırgan S, Şencan M, Tombuloğlu M, Özdemir E, Dönmez A, Görgün G, Büyükkeçeci F. An acute megakaryoblastic leukemia case with widespread osteolytic bone lesions. XIIIth Meeting of the International Society of Hematology, İstanbul, Turkey, Abstract Book, Abst. 836, September 3-8, 1995.

    Quelle: Profilseite auf medicana.com.tr

  41. Çağırgan S, Şencan M, Tombuloğlu M, Özdemir E, Dönmez A, Görgün G, Büyükkeçeci F. Two consecutive spontaneous regression to chronic phase in a patient with blastic phase chronic myelogenous leukemia. XIIIth Meeting of the International Society of Hematology, İstanbul, Turkey, Abstract Book, Abst. 863, September 3-8, 1995.

    Quelle: Profilseite auf medicana.com.tr

  42. Donmez A, Cal C, Özdemir E, Ozyurt C, Hekimgil M, Cagirgan S, Cikili N, Buyukkececi F, Soydan S: Prostatic Involvement of NonHodgkin Lymphoma. XIIIth Meeting of the International Society of Hematology, Istanbul, Turkey, 1995.

    Quelle: Profilseite auf medicana.com.tr

  43. Keser G, Koçanoğulları H, Özdemir E, Kabasakal Y, Tunçbay T, Doğanavşargil E. A case with focal myositis. VII. Mediterranean Congress of Rheumatology, Athens, Greece, Abstract Book, Abst. P48, page 84, June 16-18, 1994.

    Quelle: Profilseite auf medicana.com.tr

  44. Huri M, Akel BS, Karayazgan S, Özdemir E. Hematopoietik kök hücre nakli yapılan hastalarda nöropsikolojik fonksiyonların yaşam kalitesine olan etkisinin incelenmesi. Ergoterapi ve Rehabilitasyon Dergisi 3(2): 53-58, 2015.

    Quelle: Profilseite auf medicana.com.tr

  45. Özdemir E. Allojeneik kök hücre nakli sırasında sitomegalovirüs enfeksiyonlarının tanı ve tedavisindeki gelişmeler. Hematolog-Kemik İliği Transplantasyonu Özel Sayısı 1(1):90-95, 2011.

    Quelle: Profilseite auf medicana.com.tr

  46. Özdemir E. Paraneoplastik endokrin sendromlar; tiroid hormon bozuklukları, diabetes mellitus ve hipoglisemi. Türkiye Klinikleri J Hem Onc-Special Topics 1(3):48-50, 2008.

    Quelle: Profilseite auf medicana.com.tr

  47. Kıratlı PÖ, Erbaş B, Özdemir E, Koç Y. Ga-67 scintigraphy in lymphoma patients undergoing bone marrow transplantation. Turkish Journal of Cancer 37(2):54-58, 2007.

    Quelle: Profilseite auf medicana.com.tr

  48. Dizdar Ö, Özdemir E, Üner A, Kansu E. Images in hematology-oncology: A 40-year-old female presenting with a solitary pulmonary nodule. Turkish Journal of Cancer, 36, 35-37, 2006.

    Quelle: Profilseite auf medicana.com.tr

  49. Özdemir E. Hematopoietik Kök Hücre Nakli sonrası geç yan etkiler. Kemik İliği Transplantasyonu Özel Sayısı Turkiye Klinikleri J Int Med Sci 2(19):83-89, 2006.

    Quelle: Profilseite auf medicana.com.tr

  50. Özdemir E, Kansu E. Hacettepe Üniversitesi Onkoloji Enstitüsü hematopoietik kök hücre transplantasyonu proğramı. Hacettepe Tıp Dergisi, 36, 213-215, 2005.

    Quelle: Profilseite auf medicana.com.tr